关注
Lauro Meneghel
Lauro Meneghel
在 ki.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prevalence and thrombotic risk assessment of anti-β2 glycoprotein I domain I antibodies: a systematic review
M Radin, I Cecchi, D Roccatello, PL Meroni, S Sciascia
Seminars in thrombosis and hemostasis 44 (05), 466-474, 2018
632018
Detection of IgG anti-domain I beta2 glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome
L Meneghel, A Ruffatti, S Gavasso, M Tonello, E Mattia, L Spiezia, ...
Clinica Chimica Acta 446, 201-205, 2015
432015
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method
L Meneghel, A Ruffatti, S Gavasso, M Tonello, E Mattia, L Spiezia, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 53 (7), 1083-1089, 2015
382015
Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome
A Hoxha, A Ruffatti, E Mattia, L Meneghel, M Tonello, E Salvan, V Pengo, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 53 (8), 1265-1270, 2015
332015
IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome
E Mattia, A Ruffatti, M Tonello, L Meneghel, B Robecchi, M Pittoni, N Gallo, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 52 (9), 1329-1333, 2014
302014
The rheumatic disease‐associated FAM167A‐BLK locus encodes DIORA‐1, a novel disordered protein expressed highly in bronchial epithelium and alveolar …
L Mentlein, GE Thorlacius, L Meneghel, LA Aqrawi, JI Ramírez Sepúlveda, ...
Clinical & Experimental Immunology 193 (2), 167-177, 2018
182018
A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay
E Mattia, A Ruffatti, L Meneghel, M Tonello, D Faggian, A Hoxha, ...
Clinica Chimica Acta 446, 93-96, 2015
112015
Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block
M Ivanchenko, GE Thorlacius, M Hedlund, V Ottosson, L Meneghel, ...
Annals of the Rheumatic Diseases 80 (2), 194-202, 2021
92021
European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block
NC Kyriakidis, I Kockum, H Julkunen, A Hoxha, S Salomonsson, ...
Annals of the rheumatic diseases 77 (9), 1381-1382, 2018
82018
Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjögren’s syndrome
LA Aqrawi, L Mentlein, L Meneghel, A Björk, GE Thorlacius, M Ivanchenko, ...
Annals of the rheumatic diseases 77 (12), 1840-1842, 2018
62018
Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function
S Meisgen, M Hedlund, A Ambrosi, L Folkersen, V Ottosson, D Forsberg, ...
Annals of the Rheumatic Diseases 81 (8), 1151-1161, 2022
42022
P014 FAM167A/BLK is a susceptibility locus in autoimmune diseases: characterisation of the FAM167 gene family
L Mentlein, GE Thorlacius, L Meneghel, JIR Sepulveda, S Brauner, ...
Annals of the Rheumatic Diseases 77 (Suppl 1), A19-A19, 2018
32018
POS1431 IMMUNE CELLS AND THEIR EFFECTOR FUNCTIONS IN NEONATES BORN TO ANTI-RO/LA POSITIVE WOMEN
C Gerstner, L Rudolph, GE Thorlacius, V Ottosson, L Meneghel, ...
Annals of the Rheumatic Diseases 82 (Suppl 1), 1069-1070, 2023
2023
Clinical Correlations and Expression Pattern of the Autoimmunity Susceptibility Factor Diora-1 in Primary Sjögren’s Syndrome
L Meneghel
2018 ACR/ARHP Annual Meeting, 2018
2018
Characterization of the FAM167 gene family
L Mentlein, L Meneghel, GE Thorlacius, J Ramirez, S Brauner, ...
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 86 (4), 320-320, 2017
2017
Identification of cross-reactive targets of anti-Ro52 antibodies in congenital heart block
L Meneghel, C Mattsson, S Meisgen, P Nilsson, M Wahren-Herlenius
Scandinavian Journal of Immunology 86 (4), 321-321, 2017
2017
ANTIPHOSPHATIDYLSERINE/PROTHROMBIN ANTIBODIES AS A RISK FACTOR OF DISEASE SEVERITY IN PRIMARY ANTIPHOS-PHOLIPID SYNDROME
A Hoxha, E Mattia, M Tonello, L Meneghel, E Salvan, A Banzato, V Pengo, ...
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 (4), S40-S40, 2016
2016
Cross-reactivity of anti-Ro52 antibodies and genetic susceptibility in congenital heart block
L Meneghel
Università degli studi di Padova, 2016
2016
SAT0605 A Contribution to Detection of Anticardiolipin and Anti-β2 Glycoprotein I Antibodies: Comparison Between a Home-Made Elisa and a Fluorescence Enzyme Immunoassay
E Mattia, A Ruffatti, L Meneghel, M Tonello, D Faggian, A Hoxha, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 880-881, 2015
2015
FRI0563 Detection of IGG Anti-Domain I Beta2 Glycoprotein I Antibodies by Chemiluminescence Immunoassay in Primary Antiphospholipid Syndrome
L Meneghel, A Ruffatti, S Gavasso, M Tonello, E Mattia, L Spiezia, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 631-631, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–20